2024 Q2 Form 10-Q Financial Statement
#000109690624001137 Filed on May 15, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $12.05K | $24.05K |
YoY Change | -43.26% | -1.82% |
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $12.05K | $24.05K |
YoY Change | -43.26% | -1.82% |
Operating Profit | -$12.05K | -$24.05K |
YoY Change | -43.26% | -1.82% |
Interest Expense | ||
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | $0.00 | $0.00 |
YoY Change | ||
Pretax Income | -$12.05K | -$24.05K |
YoY Change | -43.26% | -1.82% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$12.05K | -$24.05K |
YoY Change | -43.26% | -1.82% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | ||
COMMON SHARES | ||
Basic Shares Outstanding | 1.530M shares | 1.530M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | ||
YoY Change | ||
Cash & Equivalents | $227.0K | $252.0K |
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $236.8K | $262.1K |
YoY Change | -22.88% | -22.14% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $34.50K | $34.50K |
YoY Change | 0.0% | 0.0% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $34.50K | $34.50K |
YoY Change | 0.0% | 0.0% |
TOTAL ASSETS | ||
Total Short-Term Assets | $236.8K | $262.1K |
Total Long-Term Assets | $34.50K | $34.50K |
Total Assets | $271.3K | $296.6K |
YoY Change | -20.57% | -20.08% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | ||
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $5.000K | $18.24K |
YoY Change | -23.08% | 23.03% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | ||
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | ||
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $5.000K | $18.24K |
Total Long-Term Liabilities | ||
Total Liabilities | $5.000K | $18.24K |
YoY Change | -23.08% | 23.03% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$180.8K | -$168.8K |
YoY Change | 61.36% | 85.82% |
Common Stock | $1.530K | $1.530K |
YoY Change | 0.0% | 0.0% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $266.3K | $278.3K |
YoY Change | ||
Total Liabilities & Shareholders Equity | $271.3K | $296.6K |
YoY Change | -20.57% | -20.08% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$12.05K | -$24.05K |
YoY Change | -43.26% | -1.82% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$9.362K | |
YoY Change | -7.81% | |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | $0.00 | |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | $0.00 | |
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | -$9.362K | |
Cash From Investing Activities | $0.00 | |
Cash From Financing Activities | $0.00 | |
Net Change In Cash | -$9.362K | |
YoY Change | -7.81% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$9.362K | |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-03-31 | |
CY2024Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q1 | dei |
Entity File Number
EntityFileNumber
|
333-263384 | |
CY2024Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2024Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
87-4125972 | |
CY2024Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
8211 E Regal Place | |
CY2024Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Tulsa | |
CY2024Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
OK | |
CY2024Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
74133 | |
CY2024Q1 | dei |
City Area Code
CityAreaCode
|
918 | |
CY2024Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
994-0693 | |
CY2024Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2024Q1 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2024Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
1530000 | shares |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
251976 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
261338 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
10079 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
14519 | usd |
CY2024Q1 | us-gaap |
Assets Current
AssetsCurrent
|
262055 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
275857 | usd |
CY2024Q1 | fil |
Oil And Natural Gas Properties Not Subject To Amortization
OilAndNaturalGasPropertiesNotSubjectToAmortization
|
34500 | usd |
CY2023Q4 | fil |
Oil And Natural Gas Properties Not Subject To Amortization
OilAndNaturalGasPropertiesNotSubjectToAmortization
|
34500 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
34500 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
34500 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
296555 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
310357 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
18244 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
7995 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
18244 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7995 | usd |
CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
18244 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
7995 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1530000 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1530000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1530000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1530000 | shares |
CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
1530 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1530 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
445533 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
445533 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-168752 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-144701 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
278311 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
302362 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
296555 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
310357 | usd |
CY2024Q1 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
24051 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
24496 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
24051 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
24496 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-24051 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-24496 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
0 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
0 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-24051 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-24496 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24051 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24496 | usd |
CY2024Q1 | fil |
Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
|
-0.02 | |
CY2023Q1 | fil |
Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
|
-0.02 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
380742 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24496 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
356246 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
302362 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24051 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
278311 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24051 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24496 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-4440 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-3025 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
10249 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
11316 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9362 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10155 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
|
0 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Oil And Gas Property
PaymentsToAcquireOilAndGasProperty
|
0 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
0 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
0 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-9362 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-10155 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
261338 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
336241 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
251976 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
326086 | usd |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b><i>Use of Estimates</i></b> – The preparation of financial statements in conformity with “U.S. GAAP” requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Changes in the future estimated oil and natural gas reserves or the estimated future cash flows attributable to the reserves that are utilized for impairment analysis could have a significant impact on the future results of operations.</p> | |
CY2024Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font:10pt Times New Roman;margin:0;text-align:justify"><b><i>Concentration of Credit Risk and Accounts Receivable</i></b> – Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The Company places its cash with a high credit quality financial institution.</p> | |
CY2024Q1 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
5051 | usd |
CY2023Q1 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
5144 | usd |
CY2024Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
35438 | usd |
CY2024Q1 | fil |
Monthly Lease Payment
MonthlyLeasePayment
|
79 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24051 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24496 | usd |
CY2024Q1 | fil |
Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
|
1530000 | shares |
CY2023Q1 | fil |
Basic And Diluted Weighted Average Shares Outstanding
BasicAndDilutedWeightedAverageSharesOutstanding
|
1530000 | shares |
CY2024Q1 | fil |
Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
|
-0.02 | |
CY2023Q1 | fil |
Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
|
-0.02 |